PortalRankings.com
 

Websites linking back to packageinserts.bms.com

15 websites are linking back to packageinserts.bms.com in their content.

 
Total results: 15
Domains on this page: 15
 

Results:

OPDIVO® (nivolumab) | Patient Gateway
http://portalrankings.com/info/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
  • Updated On (Date): 2016-Nov-01
  • Expiration time: 2017-Nov-06
  • Website Registered On (Date): 2012-Nov-06
Cómo ELIQUIS® (apixaban) puede ayudar | Información de seguridad
http://portalrankings.com/info/eliquisespanol.com
  • Updated On (Date): 2017-Jul-18
  • Expiration time: 2018-Jul-22
  • Website Registered On (Date): 2014-Jul-22
YERVOY®(ipilimumab) | Consumer | Gateway
http://portalrankings.com/info/yervoy.com
YERVOY® (ipilimumab), prescription medication. See Indication, Important Safety Information, and Boxed Warning.
  • Updated On (Date): 2017-May-04
  • Expiration time: 2018-May-08
  • Website Registered On (Date): 2009-May-08
OPDIVO® (nivolumab) | Information for Healthcare Professionals
http://portalrankings.com/info/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
  • Updated On (Date): 2017-Feb-27
  • Expiration time: 2018-Mar-03
  • Website Registered On (Date): 2014-Mar-03
Chemo Facts – Dr. Rath Health Foundation
http://portalrankings.com/info/chemo-facts.com
Dr Rath Foundation
  • Google Analytics code: 58365126-23
  • Updated On (Date): 2017-Oct-27
  • Expiration time: 2018-Nov-07
  • Website Registered On (Date): 2007-Nov-07
OPDIVO® (nivolumab) | Patients | Advanced Urothelial Carcinoma (Bladder Cancer)
http://portalrankings.com/info/opdivoinformation.com
Information for consumers about OPDIVO® (nivolumab), a prescription medicine for previously treated bladder cancer (urothelial carcinoma) that has spread or grown. See Indication and Important Safety Information.
  • Updated On (Date): 2017-Oct-06
  • Expiration time: 2018-Oct-10
  • Website Registered On (Date): 2016-Oct-10
Official Healthcare Professional Site | ORENCIA® (abatacept)
http://portalrankings.com/info/orenciahcp.com
Our site offers info for healthcare providers treating patients with moderate to severe rheumatoid arthritis. See Important Safety Info and Prescribing Info.
  • Updated On (Date): 2017-Feb-26
  • Expiration time: 2018-Mar-02
  • Website Registered On (Date): 2015-Mar-02
ORENCIA® (abatacept) | Official Patient Website
http://portalrankings.com/info/orencia.com
The ORENCIA® (abatacept) site provides Important Safety Information and Full Prescribing Information. Visit orencia.bmscustomerconnect.com to learn more
  • Updated On (Date): 2017-Jan-20
  • Expiration time: 2018-Jan-24
  • Website Registered On (Date): 2001-Jan-24
Resources
http://portalrankings.com/info/bmscustomerconnect.com
  • Updated On (Date): 2016-Apr-24
  • Expiration time: 2017-Apr-29
  • Website Registered On (Date): 2014-Apr-29
SPRYCEL (dasatinib) for Healthcare Professionals
http://portalrankings.com/info/sprycel-hcp.com
Find the latest safety and efficacy data for SPRYCEL® (dasatinib) for adult and pediatric patients. Visit SPRYCEL-hcp.com for more information.
  • Updated On (Date): 2017-Mar-27
  • Expiration time: 2018-Mar-31
  • Website Registered On (Date): 2010-Mar-31
COUMADIN® | What is COUMADIN®
http://portalrankings.com/info/coumadin.com
Learn about COUMADIN®, a prescription medicine. Read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.
  • Updated On (Date): 2017-Jan-15
  • Expiration time: 2018-Jan-19
  • Website Registered On (Date): 1997-Jan-18
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)
http://portalrankings.com/info/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
  • Updated On (Date): 2017-Oct-06
  • Expiration time: 2018-Oct-10
  • Website Registered On (Date): 2016-Oct-10
EMPLICITI™ (elotuzumab)
http://portalrankings.com/info/empliciti.com
Learn about EMPLICITI™ (elotuzumab) treatment which includes information about ongoing support and resources.
  • Updated On (Date): 2017-Apr-18
  • Expiration time: 2018-Apr-22
  • Website Registered On (Date): 2009-Apr-22
HIV-1 Treatment l Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
http://portalrankings.com/info/atripla.com
Learn about ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) an HIV-1 treatment. See Safety Info including Boxed WARNING and Full Prescribing Info.
  • Updated On (Date): 2017-Mar-02
  • Expiration time: 2018-Mar-29
  • Website Registered On (Date): 2005-Mar-29
SPRYCEL® (dasatinib) | SPRYCEL.com
http://portalrankings.com/info/sprycel.com
Learn about SPRYCEL® (dasatinib)
  • Updated On (Date): 2016-Jun-27
  • Expiration time: 2017-Jul-01
  • Website Registered On (Date): 2002-Jul-01
2024-05-05 17:10:20 || 0.0178